info@seagull-health.com
SeagullHealth
语言:
search
new
What Are the Purchase Channels for Opicapone (Ongentys)?
502
Article source: Seagull Pharmacy
Jan 23, 2026

Opicapone (Ongentys) is an adjunctive medication for the treatment of Parkinson’s disease. It enhances the efficacy of levodopa by inhibiting the COMT enzyme and is indicated for patients experiencing "off" episodes. As a prescription-only drug, its purchase must be conducted in strict accordance with medical guidance.

What Are the Purchase Channels for Opicapone (Ongentys)?

Overseas Purchase

Patients may consult and purchase opicapone at hospital pharmacies or licensed retail pharmacies in countries/regions where the drug has been approved for marketing.

Given that drug prices may be affected by factors such as regional variations and exchange rate fluctuations, patients are advised to make a detailed budget and plan in advance of purchase.

Purchase via Medical Service Institutions

Patients may consult domestic overseas medical service institutions that have partnerships with international pharmacies or pharmaceutical manufacturers.

These institutions typically provide legal import channels, along with professional consulting and guidance services.

Precautions for Purchasing Opicapone (Ongentys)

Purchase Strictly with a Valid Prescription

Opicapone is a prescription medication and must be prescribed by a neurologist or a Parkinson’s disease specialist based on a comprehensive assessment of the patient’s condition. Unauthorized purchase or use of another person’s prescription is prohibited.

Verify Drug Information

At the time of purchase, verify the drug name, specifications (e.g., 25mg or 50mg capsules), batch number, expiration date, and manufacturer details.

The original opicapone is manufactured by Bial-Portela, and its distribution information should be clearly traceable.

Pay Attention to Storage Conditions

The medication must be stored in an environment below 30°C.

During purchase, check whether the storage conditions in the pharmacy or throughout the delivery process meet the requirements, to avoid compromising efficacy due to exposure to high temperatures or humid environments.

Understand Contraindications and Drug Interactions

Prior to purchase, inform the prescribing physician of all medications currently being used.

Special caution should be exercised with non-selective MAO inhibitors (e.g., phenelzine, tranylcypromine) and catecholamine-based drugs (e.g., epinephrine, dopamine) to avoid potential risks arising from drug interactions.

How to Distinguish Authentic Opicapone (Ongentys) from Counterfeit Products

Inspect Packaging and Labeling

Authentic opicapone capsules come in intact packaging with clear printing.

The capsules themselves feature distinct color coding: the 50mg strength has a dark blue cap and a dark pink body, while the 25mg strength has a light blue cap and a light pink body. Both the cap and body are printed with "OPC" and the corresponding dosage.

Examine Capsule Appearance

Genuine capsules have uniform coloration and clear, non-fading printing.

Capsules that are damaged, discolored, have blurred printing, or contain foreign substances should be deemed as suspected counterfeits.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
WeChat Scan
Free Inquiry
Recommended Articles
What are the indications for Opicapone (Ongentys)?
Opicapone (Ongentys) is an oral capsule preparation, which was first approved for marketing in the United States in 2020. As a selective and reversible peripheral catechol-O-methyltransferase (COMT) i...
Dosage and Administration, Recommended Dosage of Opicapone (Ongentys)
Opicapone (Ongentys) is a novel, highly selective and reversible peripheral catechol-O-methyltransferase (COMT) inhibitor, which was approved for marketing in the United States in 2020.Dosage and Admi...
Dosage and Administration of Cenobamat: Recommended Dosage
Cenobamat is a prescription medication indicated for the treatment of focal-onset seizures in adult patients. Proper administration of this drug is crucial to ensure therapeutic efficacy and minimize ...
What Are the Indications for Cenobamat?
Cenobamat is an oral antiepileptic drug primarily indicated for the treatment of partial-onset seizures in adults. First approved in the United States in 2019, it is classified as a novel antiepilepti...
What are the Precautions for Cenobamat Administration?
Cenobamat is an antiepileptic drug indicated for the treatment of partial-onset seizures in adults. As a novel medication, its administration must be strictly in accordance with the doctor’s instructi...
Adverse Reactions of Cenobamat
Cenobamat is a medication indicated for the treatment of partial-onset seizures in adult patients. While it demonstrates significant efficacy in seizure control, like other antiepileptic drugs, it may...
What are the Precautions for Opicapone (Ongentys) Administration?
Opicapone (Ongentys) is a selective and reversible catechol-O-methyltransferase (COMT) inhibitor indicated as an adjunctive therapy to levodopa/carbidopa in patients with Parkinson’s disease for the c...
Adverse Reactions of Opicapone (Ongentys)
Opicapone (Ongentys) is an adjunctive therapeutic drug for Parkinson’s disease (PD). As a combination therapy with levodopa/carbidopa, it is indicated to reduce the occurrence of wearing-off phenomena...
Related Articles
Adverse Reactions of Opicapone (Ongentys)
Opicapone (Ongentys) is an adjunctive therapeutic drug for Parkinson’s disease (PD). As a combination therapy with levodopa/carbidopa, it is indicated to reduce the occurrence of wearing-off phenomena...
What are the Precautions for Opicapone (Ongentys) Administration?
Opicapone (Ongentys) is a selective and reversible catechol-O-methyltransferase (COMT) inhibitor indicated as an adjunctive therapy to levodopa/carbidopa in patients with Parkinson’s disease for the c...
What Are the Purchase Channels for Opicapone (Ongentys)?
Opicapone (Ongentys) is an adjunctive medication for the treatment of Parkinson’s disease. It enhances the efficacy of levodopa by inhibiting the COMT enzyme and is indicated for patients experiencing...
What are the indications for Opicapone (Ongentys)?
Opicapone (Ongentys) is an oral capsule preparation, which was first approved for marketing in the United States in 2020. As a selective and reversible peripheral catechol-O-methyltransferase (COMT) i...
Dosage and Administration, Recommended Dosage of Opicapone (Ongentys)
Opicapone (Ongentys) is a novel, highly selective and reversible peripheral catechol-O-methyltransferase (COMT) inhibitor, which was approved for marketing in the United States in 2020.Dosage and Admi...
Side Effects of Opicapone (Ongentys)
Opicapone (Ongentys) is a selective, reversible peripheral catechol-O-methyltransferase (COMT) inhibitor. It is used as an adjunctive therapy to levodopa/carbidopa to improve "off" period sy...
What Are the Precautions for Using Opicapone (Ongentys)?
Opicapone (Ongentys) is a novel peripherally selective and reversible catechol-O-methyltransferase (COMT) inhibitor that has been approved by the U.S. Food and Drug Administration (FDA) as an adjuncti...
Dosage and Administration, Recommended Dose of Opicapone (Ongentys)
Opicapone (Ongentys) is a selective, reversible peripheral catechol-O-methyltransferase (COMT) inhibitor. It is used as an adjunctive therapy to levodopa/carbidopa for the management of "off"...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • haiousales@gmail.com
Welcome to consult
Seagull Pharmacy.,Ltd All rights reserved